KG
AVXL icon

Kilter Group’s Anavex Life Sciences AVXL Stock Holding History

Kilter Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.14K Hold
1,597
– – ﹤0.01% 731
2026
Q1 		$4.9K Hold
1,597
– – ﹤0.01% 621
2025
Q4 		$5.69K Hold
1,597
– – ﹤0.01% 480
2025
Q3 		$14.2K Hold
1,597
– – 0.01% 237
2025
Q2 		$14.7K Buy
+1,597
New +$13.6K 0.01% 214

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kilter Group's AVXL Position: Q2 2026 in Review

Kilter Group held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 1,597 shares worth $4.14K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Kilter Group first reported a position in AVXL in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.7K in Q2 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Kilter Group held 1,597 shares of Anavex Life Sciences worth $4.14K as of Q2 2026.
  • Kilter Group left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #731 holding.
  • Kilter Group first reported a position in Anavex Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's Anavex Life Sciences position peaked at $14.7K in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.